Svar Life Science combines scientific expertise, assay products, services, and proprietary technology platforms to support customers in research, drug development, clinical diagnostics, and laboratory testing. Its products are used in research, clinical, and commercial laboratories worldwide, with a portfolio spanning complement assays, cell-based assays, gene therapy assays, and CCP antibody assays. The company’s iLite technology underpins reporter-gene cell-based bioassays, including assays for immune effector functions, therapeutic targets, and metabolic pathways.

Svar provides contract research services for bioanalysis, biomarker discovery, and GMP quality-control testing, alongside diagnostic testing for autoimmune and neurological disorders and therapeutic drug monitoring. It also offers custom cell-line development and cell manufacturing services. Its application support covers potency testing, safety assessment, biomarker profiling, clinical assessment, bioanalysis, regulatory testing, complement-system evaluation, gene and cell therapy, biosimilar and biobetter assessment, and metabolic therapeutics. Svar also supplies scientific resources and product documentation, including publications, webinars, technical materials, and product instructions. Through its specialist services and flexible platforms, the company supports customers across scientific and regulatory needs.